Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...

New patent expands globally protected IP estate beyond blood into alternative biofluids, positioning the Company's clinical mass spectrometry platform against traditional genomic liquid biopsies.

Man’s best friend may become cancer’s worst enemy.

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...

A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to ...

As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...